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The global incidence of pregnancy-related acute kidney injury (AKI) has reduced over recent decades because 
of improvements in reproductive health care.1–4 Pregnancy-
related AKI remains a common cause for requiring dialysis 
in low- and middle-income countries3,5,6 and is associated 
with high rates of maternal and neonatal morbidity and mor-
tality.5,7 There is limited understanding of underlying risk fac-
tors in these settings to enable appropriate triage and targeting 
of scare resources. In addition, currently published studies are 
predominantly retrospective, are limited by diverse definitions 
of AKI, and few report incidence according to Kidney Disease 
Improving Global Outcomes (KDIGO) criteria.6
Outside of pregnancy, there is increasing evidence that 
AKI is a risk factor for chronic kidney disease (CKD),8,9 and 
a recent meta-analysis of population studies has reported that 
CKD is common in low-income countries. Nearly twice as 
many women of reproductive age in low-income countries 
have CKD compared with high-income countries (9.0% 
versus 5.9%, respectively),10 but the relationship between 
pregnancy-related AKI and subsequent CKD in low- and mid-
dle-income countries is unknown.
Worldwide, hypertensive disorders of pregnancy are 
the most common cause of pregnancy-related AKI.5,7,11,12 
The Community blood pressure monitoring in Rural Africa 
and Asia: Detection of underLying preEclampsia and shock 
(CRADLE) 2 study was a prospective observational cohort of 
pregnant or postpartum women admitted with preeclampsia in 
3 state tertiary maternity units in South Africa (January 2015 
to May 2016). National laboratory databases in South Africa 
hold all routinely collected laboratory data thus facilitating 
assessment of renal recovery after AKI.
The aims of this secondary analysis of CRADLE 2 were to 
examine the incidence of pregnancy-related AKI according to 
KDIGO AKI criteria and to identify risk factors and report renal 
outcomes of women with preeclampsia who developed such AKI.
Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request. The CRADLE 2 trial was 
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Abstract—Preeclampsia is a common cause of acute kidney injury (AKI) in low- and middle-income countries, but AKI 
incidence in preeclampsia, its risk factors, and renal outcomes are unknown. A prospective observational multicenter 
study of women admitted with preeclampsia in South Africa was conducted. Creatinine concentrations were extracted 
from national laboratory databases for women with maximum creatinine of ≥90 μmol/L (≥1.02 mg/dL). Renal injury 
and recovery were defined by Kidney Disease Improving Global Outcomes creatinine criteria. Predefined risk factors, 
maternal outcomes, and neonatal outcomes were compared between AKI stages. Of 1547 women admitted with 
preeclampsia 237 (15.3%) met AKI criteria: 6.9% (n=107) stage 1, 4.3% (n=67) stage 2, and 4.1% (n=63) stage 3. There 
was a higher risk of maternal death (n=7; relative risk, 4.3; 95% CI, 1.6–11.4) and stillbirth (n=80; relative risk, 2.2; 
95% CI, 1.8–2.8) in women with AKI compared with those without. Perinatal mortality was also increased (89 of 240; 
37.1%). Hypertension in a previous pregnancy was the strongest predictor of AKI stage 2 or 3 (odds ratio, 2.24; 95% 
CI, 1.21–4.17). Renal recovery rate reduced with increasing AKI stage. A third of surviving women (76 of 230 [33.0%]) 
had not recovered baseline renal function by discharge. Approximately half (39 of 76; 51.3%) of these women had no 
further creatinine testing post-discharge. In summary, AKI was common in women with preeclampsia and had high 
rates of associated maternal and perinatal mortality. Only two-thirds of women had confirmed renal recovery. History 
of a previous hypertensive pregnancy was an important risk factor.  (Hypertension. 2019;74:1144-1151. DOI: 10.1161/
HYPERTENSIONAHA.119.13089.) • Online Data Supplement
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a prospective observational cohort study of women admitted with pree-
clampsia at 3 tertiary hospital sites (Groote Schuur Hospital, Tygerberg 
Hospital, and Kimberley Hospital) in South Africa between January 
2015 and May 2016. Any woman with a clinical diagnosis of pree-
clampsia as determined by their healthcare provider during their admis-
sion was included. Baseline and admission characteristics recorded were 
age, body mass index, parity, gestation at admission, admission systolic 
BP (SBP) and diastolic blood pressure (DBP), highest SBP during ad-
mission, DBP at highest SBP, and admission urine dipstick result (1+ 
to 3+). Prespecified clinical outcomes were eclampsia, stroke, maximal 
creatinine ≥90 µmol/L (≥1.02 mg/dL) during admission, and maternal 
and perinatal death. BP was measured using the Microlife CRADLE 
Vital Signs Alert—a device validated for use in pregnancy including pre-
eclampsia.13 The study was approved by the Ethics Committee at each 
hospital site: Stellenbosch University Ethics Committee (N14/06068), 
University of Cape Town Ethics Committees (410/2014), and the 
University of the Free State Ethics Committee (230408-011); individual 
written consent was obtained at 2 sites, and institutional-level consent 
was granted at the third site. The study was conducted in line with the 
Declarations of Helsinki. The full findings of the study are published in 
the Journal of Global Health.14 The original study was funded by Bill & 
Melinda Gates Foundation (grant ID: OPP1086183).
Serial creatinine values including any prepregnancy test results 
up until May 2017 were extracted from national laboratory databases 
in all women who had a maximum creatinine of ≥90 μmol/L during 
their admission. Hematological and biochemical test results at time 
of maximum creatinine of ≥90 μmol/L were also recorded. At one 
hospital site (Groote Schuur Hospital) where clinical records were 
available at the time of the study, original clinical notes were re-
viewed for all women who had a maximum creatinine of ≥90 μmol/L 
during admission and a random unmatched sample of 100 controls 
(maximum creatinine <90 μmol/L during admission), with 100 ID 
numbers selected using the Stata, version 14.2 (StataCorp, College 
Station, TX), random uniform() command. Candidate risk factors for 
obstetric AKI were recorded: maternal age, body mass index, gravid-
ity, parity, medical comorbidities—anemia15 (hemoglobin <9 g/dL), 
chronic hypertension (documented history or SBP >140 or diastolic 
>90 mm Hg before 20 weeks of gestation or taking antihypertensive 
medication), and HIV status—and documented history of hyperten-
sive disorder in a previous pregnancy. All 3 hospital sites gave ethical 
approval for this additional data collection as amendments to the o-
riginal ethics application. Funding for this substudy was provided by 
the British Maternal Fetal Medicine Society and a Royal College of 
Obstetricians and Gynaecologists travel award.
The KDIGO serum creatinine criteria were applied to the serial cre-
atinine data to determine AKI stage, renal recovery at discharge, and 
recovery at follow-up for all women with a maximum creatinine of 
≥90 μmol/L during admission for preeclampsia. Baseline creatinine 
was defined as the single lowest creatinine concentration <90 μmol/L 
≤2 years before admission date up until the end of May 2017. Where 
women had no creatinine value <90 μmol/L recorded, minimum cre-
atinine during admission was used as a proxy for baseline creatinine. 
Maximal creatinine was defined as the single highest creatinine con-
centration ≥90 μmol/L during admission. Discharge creatinine was 
defined as the single lowest creatinine concentration on the last day 
creatinine was recorded before and including day of discharge. Follow-
up creatinine was defined as the single lowest creatinine concentration 
post-discharge until the end of May 2017. KDIGO stage was calculated 
as per KDIGO criteria using ratios of maximum creatinine to baseline 
creatinine or minimum creatinine with a ratio of >1.5, 2, and 3 denoting 
stages 1, 2, and 3, respectively. A rise in serum creatinine concentration 
of ≥26 μmol/L in 48 hours during admission also denoted stage 1 AKI, 
and a maximum of >354 μmol/L was classed as stage 3 AKI. Recovery 
at discharge or follow-up was determined using ratios of creatinine at 
discharge and follow-up, respectively, to baseline or minimum creati-
nine concentration with a ratio of <1.5 denoting recovery.
Ordered logistic regression modeling was used to evaluate the as-
sociation between baseline demographic and clinical characteristics 
and development and severity of AKI (outcome considered as ordered 
categories: no AKI, maximum creatinine ≥90 μmol/L but AKI criteria 
not met, stage 1 AKI, stage 2 AKI, stage 3 AKI). Logistic regression 
models and area under the receiver operator curve values with 95% CIs 
were used to assess correlation between baseline demographic, clini-
cal, and admission characteristics and KDIGO score. Non parametric 
tests (Kruskal-Wallis test) were used to perform simple comparisons 
between groups. All data manipulation and analysis was performed in 
Stata, version 14.2 (StataCorp, College Station, TX).
Results
AKI Staging
One thousand five hundred forty-seven women with pree-
clampsia were recruited of whom 272 (17.6%) had a max-
imum creatinine concentration of ≥90 μmol/L (≥1.02 mg/dL) 
during admission. Of these, 15.3% (n=237) had serial changes 
in serum creatinine concentration consistent with AKI KDIGO 
criteria (Figure 1; Table 1). One woman was excluded from the 
study because she had only a single recorded creatinine concen-
tration on the national laboratory database. Of the 1547 women 
recruited, 6.9% (n=107) had stage 1 AKI, 4.3% (n=67) had 
stage 2 AKI, and 4.1% (n=63) had stage 3 AKI. The remaining 
35 women had insufficient rise in creatinine concentration to 
meet criteria for stage 1 AKI, despite a maximum creatinine 
concentration of ≥90 μmol/L during admission, or had a single 
creatinine concentration recorded in the national laboratory 
databases precluding any assessment of dynamic changes. In 
these 237 women with AKI, creatinine, urea concentrations, 
and white cell count increased across AKI stages and hemo-
globin concentration reduced (S1). Of the 32 women with stage 
3 AKI with hospital records available, 4 (12.5%) required dial-
ysis, with median duration of dialysis being 4 days (range, 2–5).
Maternal and Neonatal Outcomes Associated With 
AKI
Baseline demographics, admission characteristics and preg-
nancy, and maternal and neonatal outcomes in the groups are 
shown in Table 2. Women who developed AKI (stages 1–3) 
were more likely to die (risk ratio [RR], 4.3; 95% CI, 1.6–11.4; 
P=0.003), have had an eclamptic seizure (RR, 1.7; 95% CI, 
1.2–2.4; P=0.005), have a stroke (RR, 16.6; 95% CI, 1.7–158.8; 
P=0.015), have received magnesium sulfate (RR, 1.2; 95% CI, 
1.1–1.2; P<0.001), or be admitted to intensive care (RR, 1.9; 
95% CI, 1.6–2.2; P<0.001) compared with women who did 
not develop AKI during admission with preeclampsia. Overall, 
there were 7 maternal deaths in the women who met KDIGO 
AKI criteria (7 of 237; 3.0%), with no significant difference 
between AKI stages (P=0.803). However, rates of eclampsia 
increased with AKI stage (P for trend, 0.02; stage 3 versus stage 
1 AKI RR, 2.3; 95% CI, 1.1–4.7; P=0.02), in parallel with rates 
of intensive care unit admission (P for trend, <0.001; stage 3 
versus stage 1 AKI RR, 2.1; 95% CI, 1.5–2.9; P<0.001; stage 2 
versus stage 1 AKI RR, 1.7; 95% CI, 1.2–2.4; P=0.003).
Women who developed AKI were also more likely to experi-
ence a stillbirth (RR, 2.2; 95% CI, 1.8–2.8; P<0.001) compared 
with women without AKI. This was unchanged by adjustment 
for maximum SBP during admission, DBP at maximum SBP, 
and gestation at admission in models (odds ratio, 3.32; 95% CI, 
2.29–4.81; P<0.001 [results presented as odds ratio rather than 
RR as binomial regression models failed to converge]). There 
were no significant differences in rates of neonatal deaths be-
tween women with and without AKI (RR, 1.5; 95% CI, 0.8–3.1; 
P=0.229). Stillbirth rates increased significantly with increasing 
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1.7; 95% CI, 1.1–2.6; P=0.008), and adjustment for maximum 
SBP during admission, DBP at maximum SBP, and gestation 
at admission similarly did not alter results (stage 3 versus stage 
1 AKI odds ratio, 2.61; 95% CI, 1.29–5.27; P=0.007). Overall 
perinatal mortality in babies born to women with AKI including 
twin pregnancies was 37.1% (89 of 240).
Risk Factors for AKI
Selection for cases and controls at the single hospital site is 
shown in Figure 2. Original patient files were available for 163 
of 174 (94%) cases with maximum creatinine concentration 
≥90 µmol/L and 96 of 100 (96%) randomly selected controls 
(maximum creatinine <90 µmol/L). Maternal demographics 
and comorbidities by AKI category and stage are shown in 
Table S2 in the online-only Data Supplement. Results of indi-
vidual ordered logistic regression for each predefined risk fac-
tor are shown in Table 3. Following stepwise ordered logistic 
regression, only history of hypertensive disorder of pregnancy 
and maternal age were significant predictors of AKI (Table 3). 
The analysis was repeated using a cutoff point of stages 2 or 
more AKI to assess the robustness of this finding, and pre-
vious history of hypertensive disorder alone was also predic-
tive of stage 2 or 3 AKI (odds ratio, 2.24; 95% CI, 1.21–4.17; 
Z score, 2.56; P=0.011).
Figure 1. AKI indicates acute kidney injury; 
CRADLE, Community blood pressure 
monitoring in Rural Africa and Asia: Detection 
of underLying preEclampsia and shock; and 
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When postadmission factors (gestation at admission, ad-
mission SBP and DBP, admission urine dipstick findings, and 
maximum SBP and DBP at maximum DBP) were included 
in the stepwise logistic regression model with predefined risk 
factors, history of hypertensive disorder of pregnancy and BP 
variables remained significant predictors (Table 3). Maximum 
SBP during admission was the best individual predictor of 
AKI severity with a comparable area under the receiver oper-
ator curve to the adjusted prediction model (Table 3).
Renal Recovery at Discharge and Follow-Up
Renal recovery at discharge or during follow-up according to 
AKI stage is shown in Table 4. Overall, 154 of 230 (67.0%) sur-
viving women had recovered from AKI at discharge from hos-
pital. Rate of renal recovery at discharge reduced significantly 
with increasing stage of AKI; 95 of 105 (90.5%) women with 
stage 1 AKI while only 38 of 64 (59.3%) women with stage 2 
and 21 of 61 (34.4%) with stage 3 AKI had recovered func-
tion (P<0.01). Of the 76 women who had not recovered renal 
function at discharge, 39 (51.3%) had no further creatinine con-
centrations assessed. Of the 37 women with repeat creatinine 
concentrations post-discharge, 31 (83.8%) had renal recovery 
and 6 (16.2%) did not. These 6 women had all experienced 
stage 2 or 3 AKI. For women who recovered renal function after 
discharge, creatinine testing confirming recovery was taken at 
a median of 38 (IQR, 17–208) days after discharge. Overall 
rate of confirmed renal recovery was higher for stage 1 AKI 
(94.3%), compared with stage 2 (70.3%) and stage 3 (67.2%) 
AKI. However, many women did not have creatinine concen-
tration repeated after discharge including 23.4% of women with 
stage 2 and 29.5% of women with stage 3 AKI (Table 4).
Discussion
Principal Findings
Fifteen percent of women admitted to hospital with pree-
clampsia in this middle-income country cohort had pregnancy-
related AKI assessed by KDIGO criteria, with over half of 
cases being stage 2 or 3 in severity. Maternal death, eclampsia, 
stroke, and stillbirth rates were higher in these women than 
those without. A novel finding of this study was the high pro-
portion of women with pregnancy-related AKI with a history 
of hypertensive disorder in a previous pregnancy, also more 
frequent with increasing AKI severity. Approximately two-
thirds of women had recovered from AKI at discharge, with 
lower rates of renal recovery with more severe AKI stages. 
Overall, 2.6% of women had not recovered from AKI on fol-
low-up, all of whom had stage 2 or 3 AKI. However, overall 
rate of renal recovery in those with repeat creatinine concen-
tration testing was high, although over 50% of women with 
pregnancy-related AKI who had not recovered renal function 
at discharge had no repeat testing.
Strengths and Limitations
The strengths of this study include its large, multicenter, pro-
spective design with comprehensive national laboratory serial 
creatinine concentration data analysis, which allowed KDIGO 
staging of AKI and analysis of risk factors and outcomes 
according to AKI stage. Limitations include all centers being 
in a single country, which means findings may not be general-
izable to other low- and middle-income settings. Furthermore, 
the diagnosis of preeclampsia was a clinical diagnosis deter-
mined by healthcare provider rather than application of vali-
dated diagnostic criteria. Lack of follow-up in over half of 
women who had not recovered baseline renal function from 
AKI by discharge from hospital impacted on our ability to de-
termine the overall renal outcomes of AKI. In addition, other 
clinical events that may have affected development and se-
verity of AKI such as hemorrhage, sepsis, nephrotoxin expo-
sure, HIV viral load and fluid, and blood resuscitation, were 
not captured. Lastly, clinical record review to investigate risk 
factors for AKI was only possible at one of the 3 hospital sites 
where maternity records were available.
We found higher rates of maternal and perinatal death in 
women with AKI than in those without. Small numbers of ma-
ternal deaths precluded further analysis of the strongest clinical 
predictors of this outcome; however, our data suggest that AKI 
may be a useful surrogate marker of maternal disease severity in 
preeclampsia, given the high rates of intensive care admission 
with increasing AKI severity. The finding of higher rates of peri-
natal death in women with AKI remained significant after adjust-
ment for BP variables and gestation at admission, demonstrating 
that AKI is potentially an important independent predictor of 
poor outcome in the fetus, although further research with more 
detailed clinical data is required to validate this finding.
While equations used to calculate glomerular filtration rate 
are inaccurate in pregnancy,16,17 KDIGO AKI criteria have not 
been formally validated in pregnancy. KDIGO AKI criteria 
were chosen as this definition of AKI has gained international 
consensus.18 In calculating the KDIGO score, there were a 
small number of women (n=33) who only had raised creatinine 
concentrations of ≥90 μmol/L (≥1.02 mg/dL) on the National 
Laboratory databases. It is unknown whether these women had 
CKD or that KDIGO AKI criteria underestimated AKI severity 
of these women because of incomplete follow-up. Furthermore, 
preliminary identification of AKI by selection of the predefined 
outcome of maximum creatinine ≥90 µmol/L may have led to 
some cases of AKI being missed in women who had an incre-
ment in serum creatinine, which did not reach this threshold, 
although the renal implications of this are less clear.










1 92 (5.9) 15 (1.0) 107 (6.9)
2 60 (3.9) 7 (0.5) 67 (4.3)
3 55 (3.6) 8 (0.5) 63 (4.1)
No AKI
  MaxCr <90 μmol/L … … 1275 (82.4)
  MaxCr ≥90 μmol/L, did 
not meet AKI criteria
31 (2.0) 3 (0.2) 34 (2.2)
  Unable to score (single 
creatinine value)
… … 1 (0.1)
Total 238 (15.4) 33 (2.1) 1547 (100)
Results are displayed as n (percentage of total cohort). AKI indicates acute 
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Comparison With Other Studies
The higher rates of maternal death and stillbirth associated with 
AKI in our study is in keeping with the findings of a recent 
systematic review and meta-analysis of pregnancy outcomes 
of pregnancy-related AKI.6 However, direct comparisons of 
incidence between studies is challenging because of differing 
Table 2. Maternal Demographics, Admission Characteristics, and Delivery, Maternal and Neonatal Outcomes by AKI Category, and AKI Stage as 
Defined by Kidney Disease Improving Global Outcomes in Women With Preeclampsia
Demographic, Admission, Delivery, 
and Outcome Variables
No AKI AKI Stage
MaxCr <90
 (n=1275), μmol/L
MaxCr ≥90, AKI Criteria 







Baseline reference creatinine … … 70 [23] 61 [41] 59 [35]
Time reference creatinine taken … …    
  Prepregnancy   2 (1.9) 3 (4.5) 1 (1.6)
  Antenatal before admission   18 (16.8) 19 (28.4) 10 (15.9)
  During admission   86 (80.4) 45 (67.2) 52 (82.5)
  Postpartum after discharge   1 (0.9) 0 (0.0) 0 (0.0)
Maternal demographics (n=1547 women)
  Age at admission, y 27.5 [6.2] 26.6 [6.9] 28.4 [6.2] 28.8 [6.1] 27.4 [5.7]
  Body mass index, kg/m2* 30.5 [7.9] 26.6 [6.2] 29.4 [7.2] 31.4 [6.8] 28.9 [6.4]
  Primiparous* 480 (37.6) 17 (48.6) 33 (30.8) 18 (26.9) 16 (25.4)
Admission characteristics (n=1547 women)
  Gestation at admission, wk* 33.0 [4.9] 31.9 [4.4] 31.6 [5.0] 32.6 [4.3] 31.6 [5.3]
  Admission SBP, mm Hg* 149 [19] 147 [18] 152 [24] 157 [27] 160 [31]
  Admission DBP, mm Hg* 96 [14] 96 [15] 99 [18] 104 [19] 105 [23]
Admission urine dipstick*
  1+ 166 (13.0) 3 (8.6) 11 (10.3) 8 (11.9) 8 (12.7)
  2+ 495 (38.8) 10 (28.6) 41 (38.3) 18 (26.9) 14 (22.2)
  3+ 457 (35.8) 17 (48.6) 52 (48.6) 39 (58.2) 36 (57.1)
  Trace/negative 152 (11.9) 3 (8.6) 3 (2.8) 2 (3.0) 5 (7.9)
  Missing 5 (0.4) 2 (5.7) 0 (0.0) 0 (0.0) 0 (0.0)
Delivery and maternal outcomes (n=1547 women)
  Maximum SBP, mm Hg* 170 [15] 172 [17] 178 [18] 181 [22] 187 [25]
  Maximum DBP, mm Hg* 103 [14] 105 [18] 109 [16] 111 [18] 111 [21]
Mode of delivery
  Caesarean section 899 (70.5) 26 (74.3) 72 (67.3) 47 (70.1) 37 (58.7)
  Vaginal delivery 374 (29.3) 9 (25.7) 35 (32.7) 20 (29.9) 26 (41.3)
  Missing 2 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Eclampsia* 110 (8.6) 3 (8.6) 11 (10.3) 8 (11.9) 15 (23.8)
Stroke* 1 (0.1) 0 (0.0) 0 (0.0) 3 (4.5) 0 (0.0)
Maternal death* 8 (0.6) 1 (2.9) 2 (1.9) 3 (4.5) 2 (3.2)
ICU admission* 327 (25.6) 11 (32.4) 35 (32.7) 37 (55.2) 43 (68.3)
Use of magnesium sulfate* 1082 (84.8) 31 (91.2) 105 (98.1) 64 (95.5) 63 (100)
Neonatal outcomes (n=1589 babies)
  No. of babies 1310 39 108 69 63
Perinatal mortality
  Stillbirth* 194 (14.8) 7 (18.0) 30 (27.8) 20 (29.0) 30 (47.6)
  Neonatal death 41 (3.7) 1 (3.1) 4 (5.1) 3 (6.1) 2 (6.1)
Results are presented as mean [SD] or n (percentage). AKI indicates acute kidney injury; DBP, diastolic blood pressure; ICU, Intensive Care Unit; 
MaxCr, maximum creatinine; and SBP, systolic blood pressure.
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definitions of pregnancy-related AKI.5,19 Only 1 study reported 
outcomes according to KDIGO AKI criteria.11 Maternal death 
is reported to occur in ≤20% of cases of pregnancy-related 
AKI, with dialysis requirements ranging from 0% to 54.6%4,9,14 
with complete renal recovery in 69.4%,5 89.4%,7 and 84.6%9 
and dialysis dependence in 1.2%5 of cases. These diverse out-
comes are likely to reflect different etiologies and definitions of 
AKI. The high rate of eclampsia within our cohort is in keep-
ing with other published studies of preeclampsia from South 
Africa.20 The high rate of caesarean section is not unexpected 
Figure 2. Flow diagram illustrating selection 
of cases for clinical record review from single 
hospital site. CRADLE indicates Community 
blood pressure monitoring in Rural Africa and 
Asia: Detection of underLying preEclampsia 
and shock.
Table 3. Results of Individual and Stepwise Ordered Logistic Regression and AUROC for Predefined Clinical Predictors, With and Without Admission and 
Postadmission Variables Included in Models, for Development of AKI and Increasing AKI Severity
95% CI Z Score P Value
Predictors: predefined Odds ratio    
  Individual ordered logistic regression
   Anemia (Hb <9 g/dL) 1.22 0.47–3.16 0.42 0.678
   HIV 1.31 0.65–2.64 0.74 0.457
   Primiparous 0.72 0.45–1.13 −1.43 0.152
   Parity (increasing) 1.24 1.01–1.51 2.09 0.037
   Gravidity (increasing) 1.21 1.03–1.42 2.28 0.023
   Chronic hypertension 1.99 1.16–3.40 2.51 0.012
   History hypertensive disorder of pregnancy 2.10 1.25–3.52 2.79 0.005
   BMI category 0.92 0.76–1.11 −0.87 0.383
   Age category 1.04 1.01–1.08 2.60 0.009
  Stepwise ordered logistic regression
   History of hypertensive disorder of pregnancy 1.87 1.10–3.18 2.30 0.021
   Age category 1.03 1.00–1.07 2.09 0.037
Predictors: predefined, admission, and post-admission Odds ratio
  Stepwise ordered logistic regression
   Admission SBP 0.99 0.98–0.99 −2.14 0.032
   DBP at maximum SBP 1.02 1.00–1.04 2.48 0.013
   History of hypertensive disorder of pregnancy 1.95 1.15–3.32 2.48 0.013
   Maximum SBP 1.03 1.01–1.04 3.26 0.001
  Area under the receiver operator curve AUROC   
   Maximum SBP alone 0.66 0.59–0.73   
   Prediction model (containing all variables above) 0.71 0.64–0.77   
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as the majority of cases were of preterm preeclampsia, which 
is often associated with significant placental dysfunction which 
often precludes vaginal delivery.21,22
Established risk factors for AKI in nonpregnant populations 
include extremes of age, renal insufficiency, hypertension, dia-
betes mellitus, and cardiovascular disease.23,24 There is a paucity 
of studies investigating risk factors specifically for AKI within 
pregnancy. History of a previous pregnancy complicated by 
hypertension was identified to be associated with AKI in our 
study. The finding of a previous pregnancy complicated by hy-
pertension as a risk factor for AKI was independent of other 
risk factors and was more common with increasing severity of 
AKI. If postadmission variables were also considered, max-
imal SBP alone was the best predictor of AKI and increasing 
severity of AKI. However, of note, the models had only modest 
predictive capacity (area under the receiver operator curve of 
0.71 for combined model and 0.66 for maximum SBP alone). 
Susceptibility to AKI in patients with normal kidney function 
has recently been proposed to be increased in those with reduced 
renal reserve, that is, inability to augment glomerular filtration 
in response to protein loading.25 It is possible that a renal insult 
in a previous hypertensive pregnancy lowers functional reserve 
and contributes to reduced adaptive response in a subsequent 
pregnancy. Furthermore, preeclampsia has been reported to be 
4-fold more common in women with a previous episode of AKI 
despite complete resolution of changes in serum creatinine.26 
Thus, underlying subclinical renal disease could contribute to 
both susceptibility to recurrent preeclampsia and AKI.
In this study, the majority of women had resolution of 
AKI where follow-up data were available, with reducing rates 
of recovery with increasing AKI severity, which was also 
reported in a prospective Indian cohort study. However, in-
complete renal recovery at 3 months postpartum was higher 
(9.5%) in the Indian cohort in which only 3.5% of women 
were lost to follow-up4 compared with incomplete renal re-
covery (2.6%) in our cohort. This may represent differing AKI 
severity or an underestimation of persistent renal injury in this 
study because of inadequate repeat sampling after discharge.
Outside of pregnancy, reported rates of recovery from AKI 
have varied between 33% and 90%, which is thought to be 
accounted for by different definitions of both AKI and renal 
recovery, differences in study populations, and differences in 
timing of assessment27,28 but in general appear to be lower than 
recovery rates for women with stages 2 and 3 AKI in our study 
(68.6% confirmed renal recovery). It is possible that pregnancy 
offers some protection against kidney injury, as suggested by 
recent work in animal models,29 and in addition, studies of 
AKI in pregnancy typically involve younger, healthier cohorts 
than studies of AKI in nonpregnant populations.
Perspectives: Implications for Clinicians and Future 
Research
Awareness that recurrent preeclampsia in a second pregnancy 
may be associated with higher risk of AKI may be useful in 
triaging patients, frequency of creatinine concentration testing, 
and determining location of onward referral in low- and middle-
income country settings. In addition, the association between 
maximum SBP and risk of AKI warrants further investigation 
including whether controlling BP in hypertensive pregnant 
women reduces incidence or severity of AKI and other maternal 
and perinatal morbidities. Further research is required to deter-
mine the short- and long-term outcomes of pregnancy-related 
AKI and whether this differs according to underlying pathogen-
esis. While currently, the outcomes of this condition are not fully 
understood, we would encourage clinicians to follow-up women 
who have experienced AKI who have not recovered renal func-
tion at discharge. The relationship between hypertensive disor-
ders of pregnancy and renal reserve should be explored.
Conclusions
Our study has identified that in a middle-income setting, 
pregnancy-related AKI complicates ≈15% of admissions with 
preeclampsia, and over half of these cases are severe (stage 
2 or 3 AKI) with high rates of associated maternal (3.0%) 
and perinatal (37.1%) mortality. History of a previous hyper-
tensive disorder of pregnancy was the most significant risk 
factor for development of AKI and worsening AKI severity. 
Approximately two-thirds of women had recovered from AKI 
at discharge, but further studies are required to determine the 
short- and long-term renal outcomes of pregnancy-related AKI.
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What Is New?
•	The novel finding of this study was the high proportion of women admit-
ted with preeclampsia who developed acute kidney injury (AKI) that had 
a history of hypertensive disorder in a previous pregnancy, which was 
more frequent with increasing AKI severity.
What Is Relevant?
•	 This study demonstrates the significant burden of morbidity of hyperten-
sive disorders of pregnancy in middle-income settings; 15% of women ad-
mitted to hospital with preeclampsia had pregnancy-related AKI assessed 
by Kidney Disease Improving Global Outcomes criteria, with over half of 
cases being stage 2 or 3 in severity. Maternal death, eclampsia, stroke, 
and stillbirth rates were all higher in these women than those without.
Summary
This study has identified that in a middle-income setting, pregnan-
cy-related AKI complicates ≈15% of admissions with preeclamp-
sia, and over half of these cases are severe (stage 2 or 3 AKI) with 
high rates of maternal (3.0%), and perinatal (37.1%) mortality. 
History of a previous hypertensive disorder of pregnancy was the 
most significant risk factor for development of AKI and worsening 
AKI severity. Approximately two-thirds of women had recovered 
from AKI at discharge, but further studies are required to deter-
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